For example, researchers found that the deletion of GPR6 in mice leads to a decrease in striatal cAMP levels, an increase in locomotor activity, and slight reductions in L-DOPA or dopamine agonist-induced dyskinesia (Oeckl et al., 2014). The gene discussed is GPR6; the disease is Dyskinesia.